Epidemiologic study of gastric cancer in Iran: a systematic review

K Kalan Farmanfarma, N Mahdavifar… - Clinical and …, 2020 - Taylor & Francis
Background Gastric cancer (GC) is one of the most common cancers in Iran. Knowledge of
the epidemiology of the disease is essential in planning for prevention. So this study aimed …

[HTML][HTML] LINC00511 as a ceRNA promotes cell malignant behaviors and correlates with prognosis of hepatocellular carcinoma patients by modulating miR-195/EYA1 …

WY Hu, HY Wei, KM Li, RB Wang, XQ Xu… - Biomedicine & …, 2020 - Elsevier
Background Recently, a growing number of reports indicated that long non-coding RNAs
(lncRNAs) were involved in the development of various cancers. However, the performance …

MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer

H Guan, Z Dai, Y Ma, Z Wang… - … journal of molecular …, 2016 - spandidos-publications.com
MicroRNAs (miRNAs or miRs) regulate gene expression by negatively modulating the
stability or translational efficiency of their target genes by targeting the 3'-untranslated region …

Autoantibody profiling of glioma serum samples to identify biomarkers using human proteome arrays

P Syed, S Gupta, S Choudhary, NG Pandala, A Atak… - Scientific reports, 2015 - nature.com
The heterogeneity and poor prognosis associated with gliomas, makes biomarker
identification imperative. Here, we report autoantibody signatures across various grades of …

[HTML][HTML] EYA1 promotes cell migration and tumor metastasis in hepatocellular carcinoma

D Kong, W Ma, D Zhang, Q Cui, K Wang… - American Journal of …, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) patients are at high risk for both local recurrence and
distant metastasis and tightly associated with poor prognosis. Exploring the molecular …

[HTML][HTML] Augmented expression levels of lncRNAs ecCEBPA and UCA1 in gastric cancer tissues and their clinical significance

M Nasrollahzadeh-Khakiani… - Iranian journal of …, 2017 - ncbi.nlm.nih.gov
Objective (s): As the second cause of cancer death, gastric cancer (GC) is one of the
eminent dilemmas all over the world, therefore investigating the molecular mechanisms …

Aberrant Expression of PlncRNA-1 and TUG1: Potential Biomarkers for Gastric Cancer Diagnosis and Clinically Monitoring Cancer Progression

Z Baratieh, Z Khalaj, MA Honardoost… - Biomarkers in …, 2017 - Taylor & Francis
Aim: To evaluate PlncRNA-1, TUG1 and FAM83H-AS1 gene expression and their possible
role as a biomarker in gastric cancer (GC) progression. Patients & methods: Long noncoding …

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

P Wagner, H Schuster, J Peper, K Röhle… - 2022 - Google Patents
NZ754139A - Novel peptides and combination of peptides for use in immunotherapy against
ovarian cancer and other cancers - Google Patents NZ754139A - Novel peptides and …

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

M Andrea, T Weinschenk, H Hoerzer, O Schoor… - US Patent …, 2019 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …

miR‐622 Induces Breast Cancer Cell MCF‐7 Proliferation, Migration, and Invasion by Directly Negatively Targeting EYA1

P Tang, Y Shen, J Yang, N Wen, Y Liu… - Journal of …, 2022 - Wiley Online Library
Breast cancer is the most common female cancer in the world. Breast cancer patients are
currently treated with a combination of surgery, chemotherapy, radiotherapy, and targeted …